Halliburton Company reported that an executive serving as EVP, Secretary and Chief Legal Officer acquired additional common stock in the company. On January 2, 2026, the executive received 34,968 shares of Halliburton common stock as an award under the Halliburton Company Stock and Incentive Plan, which allows shares to be surrendered to cover tax withholding. The closing price of Halliburton common stock on the grant date was $29.60 per share.
Following this grant, the executive directly beneficially owns 368,496.49 shares of Halliburton common stock. In addition, the executive holds an option to buy 54,348 shares of common stock at an exercise price of $23.57 per share, which is exercisable and expires on January 15, 2030.
Halliburton Company’s Director, President & CEO reported a new stock award. On January 2, 2026, the executive acquired 133,458 shares of common stock at a value based on the New York Stock Exchange closing price of $29.60 per share. The shares were granted under the Halliburton Company Stock and Incentive Plan, which allows shares to be surrendered back to the company to cover tax withholding obligations.
Following this grant, the executive beneficially owns 1,131,090.02 shares of Halliburton common stock directly. The filing also lists existing stock options, including options to buy 171,200 shares at $31.44 expiring on December 5, 2028, 128,500 shares at $43.38 expiring on December 6, 2027, and 69,500 shares at $53.54 expiring on December 7, 2026.
A shareholder of HAL has filed a notice of intent to sell 100,000 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $3,225,000.00. The shares are expected to be sold on the NYSE around January 5, 2026, and the company had 841,626,610 shares outstanding at the time referenced.
The shares to be sold were accumulated over many years, primarily through restricted stock vesting as compensation from the issuer and purchases under an employee stock purchase plan funded with cash. The person selling the shares represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Halliburton Company director reports equity awards and deferred stock units. A Halliburton Co (HAL) director filed details of equity-based compensation, including stock equivalent units and restricted stock units that convert to common stock on a one-for-one basis.
On 12/30/2025, the director acquired 1,211.885 stock equivalent units under the Halliburton Company Directors' Deferred Compensation Plan, which are settled in common stock after service as a director ends. These units, along with prior accruals, totaled 12,940.639 derivative securities beneficially owned directly after the transaction.
The filing also lists several restricted stock unit awards, each representing the right to receive one share of common stock. Awards include 7,485 units from 12/2025, 7,485 units from 12/2024, 6,264.53 units from 12/2023, 5,070.76 units from 03/2023, and 4,052.66 units, all held directly. The restricted stock units generally vest in one year on the first anniversary of the award, with shares delivered either upon vesting or following cessation as a director if deferral was elected.
Halliburton Company insider holdings are reported for an officer serving as President - Eastern Hemisphere. The reporting person beneficially owns 26,283 shares of common stock in direct form.
The filing also lists several stock options to buy common stock, including options exercisable through dates ranging from 08/14/2026 to 01/02/2030, covering 11,775, 9,517, 4,323, and 7,829 underlying shares at exercise prices between $24.68 and $49.61 per share. In addition, the officer holds 17,756 restricted stock units granted in 01/2025, which vest in five equal annual installments, with one company share delivered for each unit as it vests.
Halliburton Company reported director equity activity involving restricted stock units and common shares on December 5, 2025. A block of 6,092 shares of common stock was acquired at a price of $0 following the exercise of derivative securities, increasing the director's directly held common stock to 21,375 shares.
In the derivative table, 7,485 restricted stock units granted in December 2025 were acquired, each representing one share of common stock, with 7,485 derivative securities beneficially owned afterward. Another 6,092 restricted stock units from a December 5, 2024 grant were converted, leaving no units remaining from that grant. The restricted stock units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if elected, after the director ceases service.
Halliburton Company director reports new equity award in a Form 4 filing. On 12/05/2025, the director received 7,485 restricted stock units for Halliburton common stock. Each restricted stock unit represents the right to receive one share of common stock.
The 2025 restricted stock units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if the director elected deferral, after leaving the board. Following this award, the director holds 18,768.867 shares of Halliburton common stock directly, as well as derivative holdings that include 7,485 restricted stock units from 2025 and 6,226.77 restricted stock units from a 2024 award.
Halliburton Company director reported a new equity award consisting of 7,485 restricted stock units as of 12/05/2025. Each restricted stock unit represents the right to receive one share of Halliburton common stock and generally vests in one year on the first anniversary of the award, with delivery either at vesting or, if elected, after the director leaves the board.
The filing also lists previously granted restricted stock units tied to Halliburton common stock in amounts of 6,226.77, 5,040.19 and 4,028.23 shares, along with 11,728.754 stock equivalent units accrued under the company’s Directors’ Deferred Compensation Plan, which convert into common stock on a one-for-one basis following the director’s board service.
Halliburton Company reported a routine equity compensation update for one of its directors. On December 5, 2025, the director acquired 6,092 shares of common stock at $0, following the vesting of previously granted restricted stock units from a December 5, 2024 award. After this transaction, the director directly owned 87,496 shares of Halliburton common stock.
The director was also granted a new award of 7,485 restricted stock units dated December 2025, each representing the right to receive one share of common stock. These units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if the director elected deferral, after service as a director ends.
Halliburton Company director Form 4 filing reports an equity award. On 12/05/2025, the director received 7,485 restricted stock units, each representing the right to receive one share of Halliburton common stock.
The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered either when the units vest or, if the director has elected to defer receipt, after the director ceases serving on the board. The award is reported as a derivative security held directly by the director at an exercise price of $0.